• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经囊尾蚴病所致症状性癫痫患者的生活质量。

Quality of life in patients with symptomatic epilepsy due to neurocysticercosis.

机构信息

Departamento de Epilepsia, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.

School of Medicine, Trinity College Dublin, Dublin, Ireland; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru; Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.

出版信息

Epilepsy Behav. 2022 Jun;131(Pt A):108668. doi: 10.1016/j.yebeh.2022.108668. Epub 2022 Apr 25.

DOI:10.1016/j.yebeh.2022.108668
PMID:35483205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9879681/
Abstract

BACKGROUND

Neurocysticercosis (NCC) is a common cause of late-onset epilepsy worldwide, but there is still minimal information regarding its impact on a patient's quality of life. This study evaluated quality of life in a series of patients with epilepsy secondary to NCC using the QOLIE (Quality of Life in Epilepsy)-31 questionnaire.

METHODOLOGY

This cross-sectional study included 155 Peruvian patients between 16 and 70 years of age with epilepsy due to viable intraparenchymal NCC, who enrolled in two trials of anti-parasitic treatment during the period 2006-2011. The QOLIE-31 questionnaire was applied before the onset of anti-parasitic treatment. The associations between QOLIE-31 scores, sociodemographic characteristics, clinical, and neuroimaging data were analyzed with Kruskal-Wallis test and generalized linear models (GLM).

RESULTS

The average QOLIE-31 score was 55.8 (SD ± 7.6), with 119 individuals (76.8%) scoring in the poor quality-of-life category. Generalized tonic-clonic seizures and secondarily generalized epileptic seizures were associated with a lower QOLIE-31, as well as a low level of education with a value of p = 0.05. There were no associations between QOLIE-31 scores and other variables such as sex, age, antiepileptic medication, number of parasitic cysts, and number of compromised brain regions. On multivariate analysis, a greater number of generalized epileptic seizures maintained a statistically significant association with detrimental QOLIE-31 scores.

CONCLUSION

Quality of life is affected in NCC, mainly in relation to the number of prior generalized epileptic seizures.

摘要

背景

神经囊虫病(NCC)是全球引起迟发性癫痫的常见原因,但关于其对患者生活质量的影响的信息仍然很少。本研究使用 QOLIE(癫痫生活质量)-31 问卷评估了一系列由 NCC 引起的癫痫患者的生活质量。

方法

这项横断面研究纳入了 2006 年至 2011 年期间参与两项抗寄生虫治疗试验的 155 名秘鲁患者,这些患者年龄在 16 至 70 岁之间,患有因活的脑实质内 NCC 引起的癫痫。在开始抗寄生虫治疗之前,应用 QOLIE-31 问卷进行评估。采用 Kruskal-Wallis 检验和广义线性模型(GLM)分析 QOLIE-31 评分与社会人口统计学特征、临床和神经影像学数据之间的关系。

结果

平均 QOLIE-31 评分为 55.8(SD ± 7.6),有 119 名患者(76.8%)评分处于生活质量差的类别。全面强直阵挛性发作和继发性全面性癫痫发作与 QOLIE-31 评分较低相关,文化程度较低与 p 值=0.05 相关。QOLIE-31 评分与其他变量如性别、年龄、抗癫痫药物、寄生虫囊肿数量和受影响的脑区数量之间无相关性。在多变量分析中,更多的全面性癫痫发作与 QOLIE-31 评分下降有统计学显著相关性。

结论

NCC 会影响生活质量,主要与先前全面性癫痫发作的次数有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f8/9879681/0799c63a6416/nihms-1864493-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f8/9879681/0799c63a6416/nihms-1864493-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f8/9879681/0799c63a6416/nihms-1864493-f0001.jpg

相似文献

1
Quality of life in patients with symptomatic epilepsy due to neurocysticercosis.神经囊尾蚴病所致症状性癫痫患者的生活质量。
Epilepsy Behav. 2022 Jun;131(Pt A):108668. doi: 10.1016/j.yebeh.2022.108668. Epub 2022 Apr 25.
2
Accidental injuries in patients with generalized tonic-clonic seizures. A multicenter, observational, cross-sectional study (QUIN-GTC study).全面性强直-阵挛发作患者的意外伤害。一项多中心、观察性、横断面研究(QUIN-GTC 研究)。
Epilepsy Behav. 2019 Mar;92:135-139. doi: 10.1016/j.yebeh.2018.10.043. Epub 2019 Jan 15.
3
Report of three patients with extensive neurocysticercosis in rural southern Tanzania: neurological, serological and neuroradiological findings.坦桑尼亚南部农村地区 3 例广泛神经囊虫病患者的报告:神经学、血清学和神经影像学发现。
J Med Case Rep. 2023 Jul 6;17(1):311. doi: 10.1186/s13256-023-03974-2.
4
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru.神经囊尾蚴病:秘鲁农村地区癫痫发作、血清学与脑部CT之间的关联
Neurology. 2005 Jul 26;65(2):229-33. doi: 10.1212/01.wnl.0000168828.83461.09.
5
Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis.抗癫痫药物治疗及因神经囊尾蚴病引起癫痫发作和癫痫患者的撤药建议。
Expert Rev Neurother. 2016 Sep;16(9):1079-85. doi: 10.1080/14737175.2016.1194757. Epub 2016 Jun 8.
6
Clinical presentation of neurocysticercosis-related epilepsy.神经囊尾蚴病相关性癫痫的临床表现。
Epilepsy Behav. 2017 Nov;76:151-157. doi: 10.1016/j.yebeh.2017.08.008. Epub 2017 Sep 5.
7
Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru.神经囊虫病是秘鲁囊虫病流行地区两项社区研究中癫痫和发作的病因。
PLoS Negl Trop Dis. 2014 Feb 13;8(2):e2692. doi: 10.1371/journal.pntd.0002692. eCollection 2014 Feb.
8
Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.原发性脑肿瘤患者的癫痫:对情绪、认知和健康相关生活质量的影响。
Epilepsy Behav. 2015 Jul;48:88-95. doi: 10.1016/j.yebeh.2015.03.016. Epub 2015 Jun 29.
9
Cognitive impairment and quality of life of people with epilepsy and neurocysticercosis in Zambia.赞比亚癫痫和脑囊尾蚴病患者的认知障碍和生活质量。
Epilepsy Behav. 2018 Mar;80:354-359. doi: 10.1016/j.yebeh.2017.10.042. Epub 2017 Dec 6.
10
[Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire].[癫痫患者生活质量问卷QOLIE - 10西班牙语版本的效度验证]
Neurologia. 2008 Apr;23(3):157-67.

引用本文的文献

1
The process of residual calcification following antiparasitic treatment in the pig model of neurocysticercosis is dynamic.在神经囊尾蚴病猪模型中,抗寄生虫治疗后残留钙化的过程是动态的。
PLoS Negl Trop Dis. 2025 May 5;19(5):e0013022. doi: 10.1371/journal.pntd.0013022. eCollection 2025 May.

本文引用的文献

1
Parasitic Infections of the Nervous System.神经系统寄生虫感染。
Continuum (Minneap Minn). 2021 Aug 1;27(4):943-962. doi: 10.1212/CON.0000000000000986.
2
Current Diagnostic Criteria for Neurocysticercosis.神经囊尾蚴病的现行诊断标准。
Res Rep Trop Med. 2021 Aug 10;12:197-203. doi: 10.2147/RRTM.S285393. eCollection 2021.
3
Unique Characteristics of Epilepsy Development in Neurocysticercosis.神经囊虫病致癫痫发展的独特特征。
Am J Trop Med Hyg. 2020 Aug;103(2):639-645. doi: 10.4269/ajtmh.19-0485. Epub 2020 May 14.
4
Characteristics associated with quality of life among people with drug-resistant epilepsy.耐药性癫痫患者生活质量的相关特征。
J Neurol. 2017 Jun;264(6):1174-1184. doi: 10.1007/s00415-017-8512-1. Epub 2017 May 26.
5
Validity and Reliability of the Quality of Life in Epilepsy Inventory (QOLIE-31) for Turkey.癫痫患者生活质量量表(QOLIE - 31)在土耳其的效度与信度
Noro Psikiyatr Ars. 2015 Sep;52(3):289-295. doi: 10.5152/npa.2015.8727. Epub 2015 Jul 7.
6
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.国际抗癫痫联盟对癫痫发作类型的操作性分类:国际抗癫痫联盟分类和术语委员会立场文件
Epilepsia. 2017 Apr;58(4):522-530. doi: 10.1111/epi.13670. Epub 2017 Mar 8.
7
Quality of life in epilepsy-31 inventory (QOLIE-31) scores: A global comparison.癫痫生活质量-31量表(QOLIE-31)评分:全球比较。
Epilepsy Behav. 2016 Dec;65:13-17. doi: 10.1016/j.yebeh.2016.09.032. Epub 2016 Nov 11.
8
Neurocysticercosis: An uncommon cause of drug-refractory epilepsy in North Indian population.神经囊尾蚴病:印度北部人群药物难治性癫痫的罕见病因。
Epilepsia. 2015 Nov;56(11):1747-52. doi: 10.1111/epi.13130. Epub 2015 Sep 7.
9
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.吡喹酮和阿苯达唑联合抗寄生虫疗法治疗神经囊尾蚴病的疗效:一项双盲随机对照试验。
Lancet Infect Dis. 2014 Aug;14(8):687-695. doi: 10.1016/S1473-3099(14)70779-0. Epub 2014 Jul 3.
10
Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study.乌干达国家级转诊医院中接受抗癫痫药物治疗的癫痫患者的健康相关生活质量:一项横断面研究。
Health Qual Life Outcomes. 2014 Apr 12;12:49. doi: 10.1186/1477-7525-12-49.